雪峰科技(603227) - 2025 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2025 was CNY 1,123,802,839.49, a decrease of 4.76% compared to CNY 1,179,976,455.47 in the same period last year[4] - Net profit attributable to shareholders was CNY 65,161,262.56, down 47.98% from CNY 125,251,650.65 year-on-year[4] - Basic and diluted earnings per share were both CNY 0.061, reflecting a decline of 47.86% from CNY 0.117 in the same quarter last year[4] - The decline in net profit was attributed to a decrease in sales prices of key agricultural chemical products from a subsidiary[7] - The net profit for Q1 2025 was CNY 78,994,627.66, a decrease of 40% compared to CNY 131,509,174.39 in Q1 2024[19] - Operating profit for Q1 2025 was CNY 101,977,681.82, down from CNY 165,893,754.55 in the same period last year, reflecting a decline of approximately 38.5%[19] - The total comprehensive income for Q1 2025 was a loss of CNY 7,090,931.89, contrasting with a total comprehensive income of CNY 2,342,489.51 in Q1 2024[28] Cash Flow and Liquidity - The net cash flow from operating activities increased significantly by 611.16%, reaching CNY 223,074,480.36, compared to a negative cash flow of CNY -43,641,246.31 in the previous year[4] - Cash flow from operating activities for Q1 2025 was CNY 223,074,480.36, a significant improvement from a negative cash flow of CNY 43,641,246.31 in Q1 2024[21] - The company's operating cash flow for Q1 2025 was CNY 141,000,972.86, a significant improvement from a negative cash flow of CNY 20,254,227.74 in Q1 2024[29] - The company reported a significant increase in cash and cash equivalents, reaching CNY 1,044,482,495.64 at the end of Q1 2025, up from CNY 714,575,259.28 in Q1 2024[30] Assets and Liabilities - Total assets at the end of the reporting period were CNY 7,779,406,171.50, a decrease of 1.40% from CNY 7,889,965,320.99 at the end of the previous year[5] - Total liabilities as of March 31, 2025, were CNY 1,901,159,337.98, down from CNY 2,093,398,804.24 as of December 31, 2024[16] - The company reported a decrease in total liabilities, with current liabilities at CNY 27,687,587.31, down from CNY 28,687,822.42 in the previous year[25] - The total liabilities increased to CNY 1,185,278,696.15 in 2025 from CNY 1,091,201,760.45 in 2024, reflecting a growth of approximately 8.6%[26] Equity - The equity attributable to shareholders increased by 1.39%, amounting to CNY 4,975,470,733.60 compared to CNY 4,907,054,922.32 at the end of the previous year[5] - The company’s total equity increased to CNY 5,878,246,833.52 as of March 31, 2025, from CNY 5,796,566,516.75 as of December 31, 2024[16] - The total equity decreased slightly to CNY 4,305,378,274.10 in 2025 from CNY 4,312,364,802.43 in 2024[26] Operating Costs and Profitability - Total operating costs for Q1 2025 were CNY 1,037,821,704.35, an increase of 0.2% from CNY 1,030,545,531.75 in Q1 2024[18] - Gross profit margin for Q1 2025 was approximately 7.7%, down from 12.6% in Q1 2024[18] Research and Development - Research and development expenses for Q1 2025 were CNY 1,399,454.05, compared to CNY 1,235,349.30 in Q1 2024, indicating a focus on innovation[18] - Research and development expenses for Q1 2025 were CNY 423,670.88, indicating ongoing investment in innovation[27] Other Financial Metrics - Non-recurring gains and losses amounted to CNY 3,442,323.90, primarily influenced by government subsidies and other non-operating income[6] - The company recorded a financial income of CNY 4,219,096.63 in Q1 2025, compared to CNY 1,770,340.84 in Q1 2024, showing improved financial management[27] - The company's cash and cash equivalents as of March 31, 2025, were CNY 1,140,802,051.19, up from CNY 1,004,198,307.54 as of December 31, 2024[13] - The company reported a decrease in accounts receivable from CNY 882,647,307.12 as of December 31, 2024, to CNY 819,413,620.21 as of March 31, 2025[14]